Seamless integration of antibody sequencing and screening data for lead discovery

The integration of data from high-throughput screening technologies, in silico methods and next-generation sequencing (NGS) provides crucial insights and is therefore critical for optimal lead selection. In this presentation, we will discuss an integrated data analysis method developed by ENPICOM to discover novel antibodies with the best characteristics.

What will you learn?

High-throughput sequencing of B cell repertoires and antibody libraries can accelerate and improve the discovery of novel therapeutic antibodies. However, getting from millions of sequences to a diverse set of developable antibodies with the right therapeutic properties can be incredibly challenging.

  • Common challenges in antibody discovery
  • High-throughput screening and computational approaches
  • How to easily integrate sequencing and screening data for lead discovery
Oxford Global logo.
Headshot of Jelle van Schooten.

Jelle van Schooten
Application Scientist